MIST
MIST
NASDAQ · Pharmaceuticals

Milestone Pharmaceuticals In

$0.76
+0.07 (+10.15%)
As of Nov 7, 10:42 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +5,855.7% upside
Low Target $30.70
Average Target $45.43
High Target $53.70
Current Price $0.76
Current
$0.76
Target
$45.43
$30.70 $45.43 avg $53.70
Scenario Analysis
Bear Case
$30.70
3,924.6%
Low target
Base Case
$45.43
+5,855.7%
Avg target
Bull Case
$53.70
+6,939.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.06
-75.1% from high
52-Week Low
$0.63
+20.9% from low
Target vs 52W High
$45.43
+1,384.6% vs high
Next Earnings Report
Nov 13, 2026 · Before Market Open
4d
until earnings
EPS Est: $-0.22
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%